Pages that link to "Q47791305"

The following pages link to Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study (Q47791305):

Displaying 24 items.

• Evidence for the use of intravenous immunoglobulins--a review of the literature (Q33385332) (← links)
• Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures (Q33844415) (← links)
• Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature (Q36117231) (← links)
• Serious drug rashes in children (Q36241449) (← links)
• Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date (Q36286200) (← links)
• Toxic epidermal necrolysis (TEN) Lyell's syndrome (Q36374575) (← links)
• Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis (Q36623913) (← links)
• Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology (Q36711702) (← links)
• Stevens-Johnson syndrome: pathogenesis, diagnosis, and management (Q37091877) (← links)
• Immune mediation of hypersensitivity adverse drug reactions: implications for therapy (Q37510953) (← links)
• Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis. (Q37802203) (← links)
• The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review (Q37825506) (← links)
• Toxic epidermal necrolysis and Stevens-Johnson syndrome: A review* (Q37847937) (← links)
• Skin manifestations of drug allergy (Q37863710) (← links)
• Severe drug eruptions revisited (Q37992545) (← links)
• The management of toxic epidermal necrolysis (Q38033613) (← links)
• Mycoplasma-associated Stevens-Johnson syndrome in children: retrospective review of patients managed with or without intravenous immunoglobulin, systemic corticosteroids, or a combination of therapies. (Q38271345) (← links)
• TNF-α and IFN-γ are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis (Q39275593) (← links)
• Spectrum of anticonvulsant hypersensitivity syndrome: controversy of treatment (Q40518881) (← links)
• Fatal toxic epidermal necrolysis associated with minoxidil (Q46911780) (← links)
• Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. (Q47571365) (← links)
• Case of Steven-Johnson Syndrome in a male with breast cancer secondary to docetaxel/cyclophosphamide therapy (Q51419164) (← links)
• A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis. (Q53655245) (← links)
• 9 Human Immunoglobulins (Q83232977) (← links)